23 results
424B3
ADAP
Adaptimmune Therapeutics Plc
20 Apr 23
Prospectus supplement
4:32pm
to reduce its workforce by approximately 40% and also adjust its manufacturing network.
Also, on January 5, 2023, TCR2 senior management received
S-4/A
ADAP
Adaptimmune Therapeutics Plc
18 Apr 23
Registration of securities issued in business combination transactions (amended)
4:01pm
to reduce its workforce by approximately 40% and also adjust its manufacturing network.
Also, on January 5, 2023, TCR2 senior management received
S-4
qc2crfvb701 gg
5 Apr 23
Registration of securities issued in business combination transactions
4:40pm
8-K
EX-10.1
csczh 7t0x9r31da4
4 May 22
Adaptimmune Announces Appointment of Joanna Brewer as Chief Scientific Officer
8:20am
424B5
w17wp7wap
2 Jun 20
Prospectus supplement for primary offering
5:05pm
424B5
t9hdd7pa90x71 pftdld
1 Jun 20
Prospectus supplement for primary offering
6:06am